{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:14:27Z","timestamp":1793333667930,"version":"4.5.0"},"reference-count":104,"publisher":"e-Century Publishing Corporation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/zwsr4476","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T02:52:03Z","timestamp":1748573523000},"page":"3276-3292","source":"Crossref","is-referenced-by-count":13,"title":["Role of gut-brain axis dysregulation in the pathogenesis of non-alcoholic fatty liver disease: mechanisms and therapeutic implications"],"prefix":"10.62347","volume":"17","author":[{"given":"Mei","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"EE","year":"2021","unstructured":"Powell EE, Wong VW and Rinella M. Non-alcoholic fatty liver disease. Lancet 2021; 397: 2212-2224.","journal-title":"Lancet"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41575-024-00915-2","article-title":"Spatial genomics: mapping human steatotic liver disease","volume":"21","author":"Matchett","year":"2024","unstructured":"Matchett KP, Paris J, Teichmann SA and Henderson NC. Spatial genomics: mapping human steatotic liver disease. Nat Rev Gastroenterol Hepatol 2024; 21: 646-660.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","article-title":"FXR agonists in NASH treatment","volume":"79","author":"Adorini","year":"2023","unstructured":"Adorini L and Trauner M. FXR agonists in NASH treatment. J Hepatol 2023; 79: 1317-1331.","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"JV","year":"2022","unstructured":"Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, Cortez-Pinto H, Crespo J, Cusi K, Dirac MA, Francque S, George J, Hagström H, Huang TT, Ismail MH, Kautz A, Sarin SK, Loomba R, Miller V, Newsome PN, Ninburg M, Ocama P, Ratziu V, Rinella M, Romero D, Romero-Gómez M, Schattenberg JM, Tsochatzis EA, Valenti L, Wong VW, Yilmaz Y, Younossi ZM and Zelber-Sagi S; NAFLD Consensus Consortium. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol 2022; 19: 60-78.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease","volume":"71","author":"Rosso","year":"2019","unstructured":"Rosso C, Kazankov K, Younes R, Esmaili S, Marietti M, Sacco M, Carli F, Gaggini M, Salomone F, Møller HJ, Abate ML, Vilstrup H, Gastaldelli A, George J, Grønbæk H and Bugianesi E. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease. J Hepatol 2019; 71: 1012-1021.","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jhep.2021.09.039","article-title":"Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease","volume":"76","author":"Sen","year":"2022","unstructured":"Sen P, Qadri S, Luukkonen PK, Ragnarsdottir O, McGlinchey A, Jäntti S, Juuti A, Arola J, Schlezinger JJ, Webster TF, Orešič M, Yki-Järvinen H and Hyötyläinen T. Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease. J Hepatol 2022; 76: 283-293.","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.jhep.2022.08.028","article-title":"Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease","volume":"77","author":"Mitten","year":"2022","unstructured":"Mitten EK and Baffy G. Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease. J Hepatol 2022; 77: 1642-1656.","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41586-022-05299-4","article-title":"Gut bacteria alleviate smoking-related NASH by degrading gut nicotine","volume":"610","author":"Chen","year":"2022","unstructured":"Chen B, Sun L, Zeng G, Shen Z, Wang K, Yin L, Xu F, Wang P, Ding Y, Nie Q, Wu Q, Zhang Z, Xia J, Lin J, Luo Y, Cai J, Krausz KW, Zheng R, Xue Y, Zheng MH, Li Y, Yu C, Gonzalez FJ and Jiang C. Gut bacteria alleviate smoking-related NASH by degrading gut nicotine. Nature 2022; 610: 562-568.","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","article-title":"Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"79","author":"Song","year":"2023","unstructured":"Song Q, Zhang X, Liu W, Wei H, Liang W, Zhou Y, Ding Y, Ji F, Ho-Kwan Cheung A, Wong N and Yu J. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma. J Hepatol 2023; 79: 1352-1365.","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jhep.2021.01.042","article-title":"FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease","volume":"75","author":"Liu","year":"2021","unstructured":"Liu C, Zhou B, Meng M, Zhao W, Wang D, Yuan Y, Zheng Y, Qiu J, Li Y, Li G, Xiong X, Bian H, Zhang H, Wang H, Ma X, Hu C, Xu L and Lu Y. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease. J Hepatol 2021; 75: 150-162.","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jhep.2022.04.010","article-title":"Lack of VMP1 impairs hepatic lipoprotein secretion and promotes non-alcoholic steatohepatitis","volume":"77","author":"Jiang","year":"2022","unstructured":"Jiang X, Fulte S, Deng F, Chen S, Xie Y, Chao X, He XC, Zhang Y, Li T, Li F, McCoin C, Morris EM, Thyfault J, Liu W, Li L, Davidson NO, Ding WX and Ni HM. Lack of VMP1 impairs hepatic lipoprotein secretion and promotes non-alcoholic steatohepatitis. J Hepatol 2022; 77: 619-631.","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/ijms23020662","article-title":"The intestinal barrier and its dysfunction in patients with metabolic diseases and non-alcoholic fatty liver disease","volume":"23","author":"Forlano","year":"2022","unstructured":"Forlano R, Mullish BH, Roberts LA, Thursz MR and Manousou P. The intestinal barrier and its dysfunction in patients with metabolic diseases and non-alcoholic fatty liver disease. Int J Mol Sci 2022; 23: 662.","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"ER","year":"2024","unstructured":"Mann ER, Lam YK and Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol 2024; 24: 577-595.","journal-title":"Nat Rev Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41575-023-00867-z","article-title":"Gut microbiota in overweight and obesity: crosstalk with adipose tissue","volume":"21","author":"Cani","year":"2024","unstructured":"Cani PD and Van Hul M. Gut microbiota in overweight and obesity: crosstalk with adipose tissue. Nat Rev Gastroenterol Hepatol 2024; 21: 164-183.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","unstructured":"Lavelle A and Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020; 17: 223-237.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","unstructured":"de Vos WM, Tilg H, Van Hul M and Cani PD. Gut microbiome and health: mechanistic insights. Gut 2022; 71: 1020-1032.","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3389\/fendo.2018.00443","article-title":"Dietary protein and energy balance in relation to obesity and co-morbidities","volume":"9","author":"Drummen","year":"2018","unstructured":"Drummen M, Tischmann L, Gatta-Cherifi B, Adam T and Westerterp-Plantenga M. Dietary protein and energy balance in relation to obesity and co-morbidities. Front Endocrinol (Lausanne) 2018; 9: 443.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"913842","DOI":"10.3389\/fmed.2022.913842","article-title":"Gut microbiota-modulating agents in alcoholic liver disease: links between host metabolism and gut microbiota","volume":"9","author":"Jung","year":"2022","unstructured":"Jung JH, Kim SE, Suk KT and Kim DJ. Gut microbiota-modulating agents in alcoholic liver disease: links between host metabolism and gut microbiota. Front Med (Lausanne) 2022; 9: 913842.","journal-title":"Front Med (Lausanne)"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"11604","DOI":"10.1080\/10408398.2022.2094888","article-title":"The triple interactions between gut microbiota, mycobiota and host immunity","volume":"63","author":"Yang","year":"2023","unstructured":"Yang J, Yang H and Li Y. The triple interactions between gut microbiota, mycobiota and host immunity. Crit Rev Food Sci Nutr 2023; 63: 11604-11624.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"103038","DOI":"10.1016\/j.jaut.2023.103038","article-title":"Fecal microbiota transplantation: emerging applications in autoimmune diseases","volume":"141","author":"Yang","year":"2023","unstructured":"Yang R, Chen Z and Cai J. Fecal microbiota transplantation: emerging applications in autoimmune diseases. J Autoimmun 2023; 141: 103038.","journal-title":"J Autoimmun"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"101199","DOI":"10.1016\/j.jscai.2023.101199","article-title":"Neuromodulation therapies in heart failure: a state-of-the-art review","volume":"2","author":"Pahuja","year":"2023","unstructured":"Pahuja M, Akhtar KH, Krishan S, Nasir YM, Généreux P, Stavrakis S and Dasari TW. Neuromodulation therapies in heart failure: a state-of-the-art review. J Soc Cardiovasc Angiogr Interv 2023; 2: 101199.","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.wneu.2023.02.101","article-title":"Application of vagus nerve stimulation in spinal cord injury rehabilitation","volume":"174","author":"Fallahi","year":"2023","unstructured":"Fallahi MS, Azadnajafabad S, Maroufi SF, Pour-Rashidi A, Khorasanizadeh M, Sattari SA, Faramarzi S and Slavin KV. Application of vagus nerve stimulation in spinal cord injury rehabilitation. World Neurosurg. 2023; 174: 11-24.","journal-title":"World Neurosurg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-019-0504-5","article-title":"Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice","volume":"25","author":"B&#xE1","year":"2019","unstructured":"Bárcena C, Valdés-Mas R, Mayoral P, Garabaya C, Durand S, Rodríguez F, Fernández-García MT, Salazar N, Nogacka AM, Garatachea N, Bossut N, Aprahamian F, Lucia A, Kroemer G, Freije JMP, Quirós PM and López-Otín C. Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. Nat Med 2019; 25: 1234-1242.","journal-title":"Nat Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41586-023-06466-x","article-title":"Gut microbial carbohydrate metabolism contributes to insulin resistance","volume":"621","author":"Takeuchi","year":"2023","unstructured":"Takeuchi T, Kubota T, Nakanishi Y, Tsugawa H, Suda W, Kwon AT, Yazaki J, Ikeda K, Nemoto S, Mochizuki Y, Kitami T, Yugi K, Mizuno Y, Yamamichi N, Yamazaki T, Takamoto I, Kubota N, Kadowaki T, Arner E, Carninci P, Ohara O, Arita M, Hattori M, Koyasu S and Ohno H. Gut microbial carbohydrate metabolism contributes to insulin resistance. Nature 2023; 621: 389-395.","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1456793","DOI":"10.3389\/fmicb.2024.1456793","article-title":"Microbiota-derived short chain fatty acids in pediatric health and diseases: from gut development to neuroprotection","volume":"15","author":"Hsu","year":"2024","unstructured":"Hsu CY, Khachatryan LG, Younis NK, Mustafa MA, Ahmad N, Athab ZH, Polyanskaya AV, Kasanave EV, Mirzaei R and Karampoor S. Microbiota-derived short chain fatty acids in pediatric health and diseases: from gut development to neuroprotection. Front Microbiol 2024; 15: 1456793.","journal-title":"Front Microbiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"110851","DOI":"10.1016\/j.cbi.2023.110851","article-title":"Short-chain fatty acids (SCFAs) from gastrointestinal disorders, metabolism, epigenetics, central nervous system to cancer - a mini-review","volume":"388","author":"Abdelhalim","year":"2024","unstructured":"Abdelhalim KA. Short-chain fatty acids (SCFAs) from gastrointestinal disorders, metabolism, epigenetics, central nervous system to cancer - a mini-review. Chem Biol Interact 2024; 388: 110851.","journal-title":"Chem Biol Interact"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1080\/10408398.2016.1245650","article-title":"Short-chain fatty acids in control of energy metabolism","volume":"58","author":"Hu","year":"2018","unstructured":"Hu J, Lin S, Zheng B and Cheung PCK. Short-chain fatty acids in control of energy metabolism. Crit Rev Food Sci Nutr 2018; 58: 1243-1249.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"116383","DOI":"10.1016\/j.bcp.2024.116383","article-title":"The short-chain fatty acid acetate modulates orexin\/hypocretin neurons: a novel mechanism in gut-brain axis regulation of energy homeostasis and feeding","volume":"226","author":"Forte","year":"2024","unstructured":"Forte N, Marfella B, Nicois A, Palomba L, Paris D, Motta A, Pina Mollica M, Di Marzo V and Cristino L. The short-chain fatty acid acetate modulates orexin\/hypocretin neurons: a novel mechanism in gut-brain axis regulation of energy homeostasis and feeding. Biochem Pharmacol 2024; 226: 116383.","journal-title":"Biochem Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1515\/mr-2024-0011","article-title":"Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism","volume":"4","author":"Hoffman","year":"2024","unstructured":"Hoffman S and Adeli K. Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism. Med Rev (2021) 2024; 4: 301-311.","journal-title":"Med Rev (2021)"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","unstructured":"Jia W, Xie G and Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol 2018; 15: 111-128.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"169603","DOI":"10.1016\/j.scitotenv.2023.169603","article-title":"Chronic sucralose consumption inhibits farnesoid X receptor signaling and perturbs lipid and cholesterol homeostasis in the mouse livers, potentially by altering gut microbiota functions","volume":"919","author":"Chi","year":"2024","unstructured":"Chi L, YifeiYang, Bian X, Gao B, Tu P, Ru H and Lu K. Chronic sucralose consumption inhibits farnesoid X receptor signaling and perturbs lipid and cholesterol homeostasis in the mouse livers, potentially by altering gut microbiota functions. Sci Total Environ 2024; 919: 169603.","journal-title":"Sci Total Environ"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"12359","DOI":"10.1074\/jbc.RA119.007409","article-title":"Murine macrophage autophagy protects against alcohol-induced liver injury by degrading interferon regulatory factor 1 (IRF1) and removing damaged mitochondria","volume":"294","author":"Liang","year":"2019","unstructured":"Liang S, Zhong Z, Kim SY, Uchiyama R, Roh YS, Matsushita H, Gottlieb RA and Seki E. Murine macrophage autophagy protects against alcohol-induced liver injury by degrading interferon regulatory factor 1 (IRF1) and removing damaged mitochondria. J Biol Chem 2019; 294: 12359-12369.","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.33963\/KP.a2023.0115","article-title":"Gut dysbiosis-derived low-grade endotoxemia: a common basis for liver and cardiovascular disease","volume":"81","author":"Violi","year":"2023","unstructured":"Violi F, Nocella C, Bartimoccia S, Castellani V, Carnevale R, Pignatelli P and Cammisotto V. Gut dysbiosis-derived low-grade endotoxemia: a common basis for liver and cardiovascular disease. Kardiol Pol 2023; 81: 563-571.","journal-title":"Kardiol Pol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jhep.2022.04.010","article-title":"Lack of VMP1 impairs hepatic lipoprotein secretion and promotes non-alcoholic steatohepatitis","volume":"77","author":"Jiang","year":"2022","unstructured":"Jiang X, Fulte S, Deng F, Chen S, Xie Y, Chao X, He XC, Zhang Y, Li T, Li F, McCoin C, Morris EM, Thyfault J, Liu W, Li L, Davidson NO, Ding WX and Ni HM. Lack of VMP1 impairs hepatic lipoprotein secretion and promotes non-alcoholic steatohepatitis. J Hepatol 2022; 77: 619-631.","journal-title":"J Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1117644","DOI":"10.3389\/fmicb.2023.1117644","article-title":"Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism","volume":"14","author":"Zhang","year":"2023","unstructured":"Zhang XL, Chen L, Yang J, Zhao SS, Jin S, Ao N, Yang J, Liu HX and Du J. Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism. Front Microbiol 2023; 14: 1117644.","journal-title":"Front Microbiol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3390\/ijms25031807","article-title":"Gut microbiota in patients with non-alcoholic fatty liver disease without type 2 diabetes: stratified by body mass index","volume":"25","author":"Chuaypen","year":"2024","unstructured":"Chuaypen N, Asumpinawong A, Sawangsri P, Khamjerm J, Iadsee N, Jinato T, Sutheeworapong S, Udomsawaengsup S and Tangkijvanich P. Gut microbiota in patients with non-alcoholic fatty liver disease without type 2 diabetes: stratified by body mass index. Int J Mol Sci.2024; 25: 1807.","journal-title":"Int J Mol Sci"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Ju T, Bourrie BCT, Forgie AJ, Pepin DM, Tollenaar S, Sergi CM and Willing BP. The gut commensal escherichia coli aggravates high-fat-diet-induced obesity and insulin resistance in mice. Appl Environ Microbiol 2023; 89: e0162822.","DOI":"10.1128\/aem.01628-22"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41579-019-0213-6","article-title":"Microbial genes and pathways in inflammatory bowel disease","volume":"17","author":"Schirmer","year":"2019","unstructured":"Schirmer M, Garner A, Vlamakis H and Xavier RJ. Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol 2019; 17: 497-511.","journal-title":"Nat Rev Microbiol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"14918","DOI":"10.3390\/ijms241914918","article-title":"Prebiotics and probiotics: therapeutic tools for nonalcoholic fatty liver disease","volume":"24","author":"Mijangos-Trejo A","year":"2023","unstructured":"Mijangos-Trejo A, Nuño-Lambarri N, Barbero-Becerra V, Uribe-Esquivel M, Vidal-Cevallos P and Chávez-Tapia N. Prebiotics and probiotics: therapeutic tools for nonalcoholic fatty liver disease. Int J Mol Sci 2023; 24: 14918.","journal-title":"Int J Mol Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3390\/biology11111622","article-title":"Gut-liver axis and non-alcoholic fatty liver disease: a vicious circle of dysfunctions orchestrated by the gut microbiome","volume":"11","author":"Pezzino","year":"2022","unstructured":"Pezzino S, Sofia M, Faletra G, Mazzone C, Litrico G, La Greca G and Latteri S. Gut-liver axis and non-alcoholic fatty liver disease: a vicious circle of dysfunctions orchestrated by the gut microbiome. Biology (Basel) 2022; 11: 1622.","journal-title":"Biology (Basel)"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR and Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med 2024; 19: 275-293.","journal-title":"Intern Emerg Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"16443","DOI":"10.3748\/wjg.v20.i44.16443","article-title":"Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease","volume":"20","author":"Ceccarelli","year":"2014","unstructured":"Ceccarelli S, Nobili V and Alisi A. Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease. World J Gastroenterol 2014; 20: 16443-16451.","journal-title":"World J Gastroenterol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-1-0716-3429-5_19","article-title":"Determination of tight junction integrity in brain endothelial cells based on tight junction protein expression","volume":"2711","author":"Alluri","year":"2024","unstructured":"Alluri H, Peddaboina CS and Tharakan B. Determination of tight junction integrity in brain endothelial cells based on tight junction protein expression. Methods Mol Biol 2024; 2711: 235-240.","journal-title":"Methods Mol Biol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","unstructured":"Zhang X, Coker OO, Chu ES, Fu K, Lau HCH, Wang YX, Chan AWH, Wei H, Yang X, Sung JJY and Yu J. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut 2021; 70: 761-774.","journal-title":"Gut"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1053\/j.gastro.2020.06.038","article-title":"IL1B increases intestinal tight junction permeability by up-regulation of MIR200C-3p, which degrades occludin mRNA","volume":"159","author":"Rawat","year":"2020","unstructured":"Rawat M, Nighot M, Al-Sadi R, Gupta Y, Viszwapriya D, Yochum G, Koltun W and Ma TY. IL1B increases intestinal tight junction permeability by up-regulation of MIR200C-3p, which degrades occludin mRNA. Gastroenterology 2020; 159: 1375-1389.","journal-title":"Gastroenterology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3390\/metabo14120704","article-title":"The role of diet, additives, and antibiotics in metabolic endotoxemia and chronic diseases","volume":"14","author":"Park","year":"2024","unstructured":"Park JE, Park HY, Kim YS and Park M. The role of diet, additives, and antibiotics in metabolic endotoxemia and chronic diseases. Metabolites 2024; 14: 704.","journal-title":"Metabolites"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Zheng M, Zhai Y, Yu Y, Shen J, Chu S, Focaccia E, Tian W, Wang S, Liu X, Yuan X, Wang Y, Li L, Feng B, Li Z, Guo X, Qiu J, Zhang C, Hou J, Sun Y, Yang X, Zuo X, Heikenwalder M, Li Y, Yuan D and Li S. TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response. Cell Metab 2024; 36: 2086-2103, e9.","DOI":"10.1016\/j.cmet.2024.06.008"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/JPER.22-0205","article-title":"Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism","volume":"94","author":"Lin","year":"2023","unstructured":"Lin S, Zhang X, Zhu X, Jiao J, Wu Y, Li Y and Zhao L. Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism. J Periodontol 2023; 94: 405-418.","journal-title":"J Periodontol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1055\/s-0041-1726093","article-title":"Protective role of activated protein C against viral mimetic poly(I:C)-induced inflammation","volume":"121","author":"Cai","year":"2021","unstructured":"Cai X, Panicker SR, Biswas I, Giri H and Rezaie AR. Protective role of activated protein C against viral mimetic poly(I:C)-induced inflammation. Thromb Haemost 2021; 121: 1448-1463.","journal-title":"Thromb Haemost"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Bekeredjian-Ding I, Stein C and Uebele J. The innate immune response against staphylococcus aureus. Curr Top Microbiol Immunol 2017; 409: 385-418.","DOI":"10.1007\/82_2015_5004"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-3-031-63657-8_9","article-title":"Message transmission between adipocyte and macrophage in obesity","volume":"1460","author":"Engin","year":"2024","unstructured":"Engin AB. Message transmission between adipocyte and macrophage in obesity. Adv Exp Med Biol 2024; 1460: 273-295.","journal-title":"Adv Exp Med Biol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"9605894","DOI":"10.1155\/2017\/9605894","article-title":"Toll-like receptor 4 signalling and its impact on platelet function, thrombosis, and haemostasis","volume":"2017","author":"Vallance","year":"2017","unstructured":"Vallance TM, Zeuner MT, Williams HF, Widera D and Vaiyapuri S. Toll-like receptor 4 signalling and its impact on platelet function, thrombosis, and haemostasis. Mediators Inflamm 2017; 2017: 9605894.","journal-title":"Mediators Inflamm"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","volume":"24","author":"Neurath","year":"2024","unstructured":"Neurath MF. Strategies for targeting cytokines in inflammatory bowel disease. Nat Rev Immunol 2024; 24: 559-576.","journal-title":"Nat Rev Immunol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1038\/s41467-023-39311-w","article-title":"Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages","volume":"14","author":"Groeger","year":"2023","unstructured":"Groeger M, Matsuo K, Heidary Arash E, Pereira A, Le Guillou D, Pino C, Telles-Silva KA, Maher JJ, Hsiao EC and Willenbring H. Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages. Nat Commun 2023; 14: 3902.","journal-title":"Nat Commun"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"446","DOI":"10.23736\/s2724-5985.23.03361-2","article-title":"Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease","volume":"70","author":"Castelnuovo","year":"2024","unstructured":"Castelnuovo G, Perez-Diaz-Del-Campo N, Guariglia M, Poggiolini I, Armandi A, Rosso C, Caviglia GP and Bugianesi E. Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease. Minerva Gastroenterol (Torino) 2024; 70: 446-453.","journal-title":"Minerva Gastroenterol (Torino)"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"101958","DOI":"10.1016\/j.arr.2023.101958","article-title":"RNA binding proteins in senescence: a potential common linker for age-related diseases?","volume":"88","author":"Varesi","year":"2023","unstructured":"Varesi A, Campagnoli LIM, Barbieri A, Rossi L, Ricevuti G, Esposito C, Chirumbolo S, Marchesi N and Pascale A. RNA binding proteins in senescence: a potential common linker for age-related diseases?. Ageing Res Rev 2023; 88: 101958.","journal-title":"Ageing Res Rev"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.3390\/ijms22094628","article-title":"Resveratrol, metabolic dysregulation, and Alzheimer’s disease: considerations for neurogenerative disease","volume":"22","author":"AJT","year":"2021","unstructured":"Yang AJT, Bagit A and MacPherson REK. Resveratrol, metabolic dysregulation, and Alzheimer’s disease: considerations for neurogenerative disease. Int J Mol Sci 2021; 22: 4628.","journal-title":"Int J Mol Sci"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"112166","DOI":"10.1016\/j.yexcr.2020.112166","article-title":"LRP1 knockdown aggravates Aβ1-42-stimulated microglial and astrocytic neuroinflammatory responses by modulating TLR4\/NF-κB\/MAPKs signaling pathways","volume":"394","author":"He","year":"2020","unstructured":"He Y, Ruganzu JB, Jin H, Peng X, Ji S, Ma Y, Zheng L and Yang W. LRP1 knockdown aggravates Aβ1-42-stimulated microglial and astrocytic neuroinflammatory responses by modulating TLR4\/NF-κB\/MAPKs signaling pathways. Exp Cell Res 2020; 394: 112166.","journal-title":"Exp Cell Res"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1042\/CS20220777","article-title":"The leaky gut and the gut microbiome in sepsis - targets in research and treatment","volume":"137","author":"Chancharoenthana","year":"2023","unstructured":"Chancharoenthana W, Kamolratanakul S, Schultz MJ and Leelahavanichkul A. The leaky gut and the gut microbiome in sepsis - targets in research and treatment. Clin Sci (Lond) 2023; 137: 645-662.","journal-title":"Clin Sci (Lond)"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1260793","DOI":"10.3389\/fmicb.2024.1260793","article-title":"Microbial dysbiosis and the aging process: a review on the potential age-deceleration role of Lactiplantibacillus plantarum","volume":"15","author":"Gupta","year":"2024","unstructured":"Gupta N, El-Gawaad NSA, Mallasiy LO, Gupta H, Yadav VK, Alghamdi S and Qusty NF. Microbial dysbiosis and the aging process: a review on the potential age-deceleration role of Lactiplantibacillus plantarum. Front Microbiol 2024; 15: 1260793.","journal-title":"Front Microbiol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1087091","DOI":"10.3389\/fcell.2023.1087091","article-title":"Towards early detection of neurodegenerative diseases: a gut feeling","volume":"11","author":"Makdissi","year":"2023","unstructured":"Makdissi S, Parsons BD and Di Cara F. Towards early detection of neurodegenerative diseases: a gut feeling. Front Cell Dev Biol 2023; 11: 1087091.","journal-title":"Front Cell Dev Biol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.brainresbull.2021.04.010","article-title":"Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: avenues for therapeutic intervention","volume":"172","author":"Bhuiyan","year":"2021","unstructured":"Bhuiyan P, Chen Y, Karim M, Dong H and Qian Y. Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: avenues for therapeutic intervention. Brain Res Bull 2021; 172: 61-78.","journal-title":"Brain Res Bull"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3389\/fendo.2018.00741","article-title":"Gut mechanisms linking intestinal sweet sensing to glycemic control","volume":"9","author":"Kreuch","year":"2018","unstructured":"Kreuch D, Keating DJ, Wu T, Horowitz M, Rayner CK and Young RL. Gut mechanisms linking intestinal sweet sensing to glycemic control. Front Endocrinol (Lausanne) 2018; 9: 741.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12974-021-02255-3","article-title":"EETs\/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model","volume":"18","author":"Liu","year":"2021","unstructured":"Liu T, Li T, Chen X, Li Z, Feng M, Yao W, Wan L, Zhang C and Zhang Y. EETs\/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model. J Neuroinflammation 2021; 18: 211.","journal-title":"J Neuroinflammation"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.4103\/1673-5374.373674","article-title":"Axonal growth inhibitors and their receptors in spinal cord injury: from biology to clinical translation","volume":"18","author":"Chambel","year":"2023","unstructured":"Chambel SS and Cruz CD. Axonal growth inhibitors and their receptors in spinal cord injury: from biology to clinical translation. Neural Regen Res. 2023; 18: 2573-2581.","journal-title":"Neural Regen Res"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"2300016","DOI":"10.1002\/elsc.202300016","article-title":"Gut microbiota induced epigenetic modifications in the non-alcoholic fatty liver disease pathogenesis","volume":"24","author":"Tang","year":"2024","unstructured":"Tang R, Liu R, Zha H, Cheng Y, Ling Z and Li L. Gut microbiota induced epigenetic modifications in the non-alcoholic fatty liver disease pathogenesis. Eng Life Sci 2024; 24: 2300016.","journal-title":"Eng Life Sci"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Vegda HS, Patel B, Girdhar GA, Pathan MSH, Ahmad R, Haque M, Sinha S and Kumar S. Role of nonalcoholic fatty liver disease in periodontitis: a bidirectional relationship. Cureus 2024; 16: e63775.","DOI":"10.7759\/cureus.63775"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"117134","DOI":"10.1016\/j.envres.2023.117134","article-title":"Dissecting the role of cadmium, lead, arsenic, and mercury in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"238","author":"Tinkov","year":"2023","unstructured":"Tinkov AA, Aschner M, Santamaria A, Bogdanov AR, Tizabi Y, Virgolini MB, Zhou JC and Skalny AV. Dissecting the role of cadmium, lead, arsenic, and mercury in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Environ Res 2023; 238: 117134.","journal-title":"Environ Res"},{"key":"ref68","unstructured":"Brüler BC, Vieira TC, Wolf M, Lucina SB, Montiani-Ferreira F and Sousa MG. Using the oculocardiac reflex to characterize autonomic imbalance in a naturally occurring canine model of valvular insufficiency. Comp Med 2018; 68: 156-162."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbi.2024.11.023","article-title":"The vagus nerve: an old but new player in brain-body communication","volume":"124","author":"Ma","year":"2024","unstructured":"Ma L, Wang HB and Hashimoto K. The vagus nerve: an old but new player in brain-body communication. Brain Behav Immun 2024; 124: 28-39.","journal-title":"Brain Behav Immun"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s13205-024-04126-z","article-title":"Ex vivo and miniaturized in vitro models to study microbiota-gut-brain axis","volume":"14","author":"Yata","year":"2024","unstructured":"Yata VK. Ex vivo and miniaturized in vitro models to study microbiota-gut-brain axis. 3 Biotech 2024; 14: 280.","journal-title":"3 Biotech"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.1021\/acs.jafc.3c08454","article-title":"Modulation of gut microbial metabolism by cyanidin-3-O-glucoside in mitigating polystyrene-induced colonic inflammation: insights from 16S rRNA sequencing and metabolomics","volume":"72","author":"Chen","year":"2024","unstructured":"Chen W, Zheng X, Yan F, Xu L and Ye X. Modulation of gut microbial metabolism by cyanidin-3-O-glucoside in mitigating polystyrene-induced colonic inflammation: insights from 16S rRNA sequencing and metabolomics. J Agric Food Chem 2024; 72: 7140-7154.","journal-title":"J Agric Food Chem"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12020-015-0658-y","article-title":"Hypothalamic-autonomic control of energy homeostasis","volume":"50","author":"Seoane-Collazo P","year":"2015","unstructured":"Seoane-Collazo P, Fernø J, Gonzalez F, Diéguez C, Leis R, Nogueiras R and López M. Hypothalamic-autonomic control of energy homeostasis. Endocrine 2015; 50: 276-291.","journal-title":"Endocrine"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00284-022-03150-7","article-title":"Gastrointestinal tract, microbiota and Multiple Sclerosis (MS) and the link between gut microbiota and CNS","volume":"80","author":"Yousefi","year":"2022","unstructured":"Yousefi B, Babaeizad A, Banihashemian SZ, Feyzabadi ZK, Dadashpour M, Pahlevan D, Ghaffari H and Eslami M. Gastrointestinal tract, microbiota and Multiple Sclerosis (MS) and the link between gut microbiota and CNS. Curr Microbiol 2022; 80: 38.","journal-title":"Curr Microbiol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"625836","DOI":"10.3389\/fmed.2021.625836","article-title":"Vagus nerve stimulation: a potential adjunct therapy for COVID-19","volume":"8","author":"Azabou","year":"2021","unstructured":"Azabou E, Bao G, Bounab R, Heming N and Annane D. Vagus nerve stimulation: a potential adjunct therapy for COVID-19. Front Med (Lausanne) 2021; 8: 625836.","journal-title":"Front Med (Lausanne)"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R and Soleimanpour S. A comprehensive review on the role of the gut microbiome in human neurological disorders. Clin Microbiol Rev 2022; 35: e0033820.","DOI":"10.1128\/CMR.00338-20"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41575-021-00512-7","article-title":"Leveraging diet to engineer the gut microbiome","volume":"18","author":"Wolter","year":"2021","unstructured":"Wolter M, Grant ET, Boudaud M, Steimle A, Pereira GV, Martens EC and Desai MS. Leveraging diet to engineer the gut microbiome. Nat Rev Gastroenterol Hepatol 2021; 18: 885-902.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"154404","DOI":"10.1016\/j.phymed.2022.154404","article-title":"superfine powder on metabolic hypertensive rats via gut-derived LPS\/TLR4 pathway inhibition","volume":"106","author":"Su","year":"2022","unstructured":"Su J, Wang Y, Yan M, He Z, Zhou Y, Xu J, Li B, Xu W, Yu J, Chen S and Lv G. The beneficial effects of Polygonatum sibiricum Red. superfine powder on metabolic hypertensive rats via gut-derived LPS\/TLR4 pathway inhibition. Phytomedicine 2022; 106: 154404.","journal-title":"Phytomedicine"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1021\/acs.jafc.0c07407","article-title":") pulp phenolics activate the short-chain fatty acid-free fatty acid receptor anti-inflammatory pathway by regulating microbiota and mitigate intestinal barrier damage in dextran sulfate sodium-induced colitis in mice","volume":"69","author":"Huang","year":"2021","unstructured":"Huang G, Wang Z, Wu G, Zhang R, Dong L, Huang F, Zhang M and Su D. Lychee (Litchi chinensis Sonn.) pulp phenolics activate the short-chain fatty acid-free fatty acid receptor anti-inflammatory pathway by regulating microbiota and mitigate intestinal barrier damage in dextran sulfate sodium-induced colitis in mice. J Agric Food Chem 2021; 69: 3326-3339.","journal-title":"J Agric Food Chem"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12876-024-03356-y","article-title":"Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Pan","year":"2024","unstructured":"Pan Y, Yang Y, Wu J, Zhou H and Yang C. Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. BMC Gastroenterol 2024; 24: 283.","journal-title":"BMC Gastroenterol"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"8210","DOI":"10.1038\/s41467-023-43448-z","article-title":"Identification of inulin-responsive bacteria in the gut microbiota via multi-modal activity-based sorting","volume":"14","author":"Riva","year":"2023","unstructured":"Riva A, Rasoulimehrabani H, Cruz-Rubio JM, Schnorr SL, von Baeckmann C, Inan D, Nikolov G, Herbold CW, Hausmann B, Pjevac P, Schintlmeister A, Spittler A, Palatinszky M, Kadunic A, Hieger N, Del Favero G, von Bergen M, Jehmlich N, Watzka M, Lee KS, Wiesenbauer J, Khadem S, Viernstein H, Stocker R, Wagner M, Kaiser C, Richter A, Kleitz F and Berry D. Identification of inulin-responsive bacteria in the gut microbiota via multi-modal activity-based sorting. Nat Commun 2023; 14: 8210.","journal-title":"Nat Commun"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1039\/D2FO02710K","article-title":"β(2 → 1)-β(2 → 6) branched graminan-type fructans and β(2 → 1) linear fructans impact mucus-related and endoplasmic reticulum stress-related genes in goblet cells and attenuate inflammatory responses in a fructan dependent fashion","volume":"14","author":"Fern&#xE1","year":"2023","unstructured":"Fernández-Lainez C, Aan de Stegge M, Silva-Lagos LA, López-Velázquez G and de Vos P. β(2 → 1)-β(2 → 6) branched graminan-type fructans and β(2 → 1) linear fructans impact mucus-related and endoplasmic reticulum stress-related genes in goblet cells and attenuate inflammatory responses in a fructan dependent fashion. Food Funct 2023; 14: 1338-1348.","journal-title":"Food Funct"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1439176","DOI":"10.3389\/fimmu.2024.1439176","article-title":"Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review","volume":"15","author":"Karimi","year":"2024","unstructured":"Karimi M, Shirsalimi N, Hashempour Z, Salehi Omran H, Sedighi E, Beigi F and Mortezazadeh M. Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review. Front Immunol 2024; 15: 1439176.","journal-title":"Front Immunol"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41568-023-00658-3","article-title":"Translating p53-based therapies for cancer into the clinic","volume":"24","author":"Peuget","year":"2024","unstructured":"Peuget S, Zhou X and Selivanova G. Translating p53-based therapies for cancer into the clinic. Nat Rev Cancer 2024; 24: 192-215.","journal-title":"Nat Rev Cancer"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1272479","DOI":"10.3389\/fmicb.2023.1272479","article-title":"Gut macrobiotic and its metabolic pathways modulate cardiovascular disease","volume":"14","author":"Zhu","year":"2023","unstructured":"Zhu J, Lyu J, Zhao R Liu G and Wang S. Gut macrobiotic and its metabolic pathways modulate cardiovascular disease. Front Microbiol 2023; 14: 1272479.","journal-title":"Front Microbiol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"2390164","DOI":"10.1080\/19490976.2024.2390164","article-title":"Time-restricted feeding ameliorates non-alcoholic fatty liver disease through modulating hepatic nicotinamide metabolism via gut microbiota remodeling","volume":"16","author":"Feng","year":"2024","unstructured":"Feng R, Yang W, Feng W, Huang X, Cen M, Peng G, Wu W, Wang Z, Jing Y, Long T, Liu Y, Li Z, Chang G and Huang K. Time-restricted feeding ameliorates non-alcoholic fatty liver disease through modulating hepatic nicotinamide metabolism via gut microbiota remodeling. Gut Microbes 2024; 16: 2390164.","journal-title":"Gut Microbes"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.1038\/s41598-023-34746-z","article-title":"Transcutaneous auricular vagus nerve stimulation as a potential novel treatment for polycystic ovary syndrome","volume":"13","author":"Zhang","year":"2023","unstructured":"Zhang S, He H, Wang Y, Wang X and Liu X. Transcutaneous auricular vagus nerve stimulation as a potential novel treatment for polycystic ovary syndrome. Sci Rep 2023; 13: 7721.","journal-title":"Sci Rep"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","unstructured":"Kazankov K, Jørgensen SMD, Thomsen KL, Møller HJ, Vilstrup H, George J, Schuppan D and Grønbæk H. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol 2019; 16: 145-159.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"120956","DOI":"10.1016\/j.lfs.2022.120956","article-title":"Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms","volume":"308","author":"Shaaban","year":"2022","unstructured":"Shaaban HH, Alzaim I, El-Mallah A, Aly RG, El-Yazbi AF and Wahid A. Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms. Life Sci 2022; 308: 120956.","journal-title":"Life Sci"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"107438","DOI":"10.1016\/j.intimp.2021.107438","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease through targeting Nr4A1 in macrophages","volume":"94","author":"Sun","year":"2021","unstructured":"Sun B, Zhang R, Liang Z, Fan A and Kang D. Hyperoside attenuates non-alcoholic fatty liver disease through targeting Nr4A1 in macrophages. Int Immunopharmacol 2021; 94: 107438.","journal-title":"Int Immunopharmacol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MOL.0000000000000878","article-title":"Bempedoic acid for nonalcoholic fatty liver disease: evidence and mechanisms of action","volume":"34","author":"Roglans","year":"2023","unstructured":"Roglans N, Laguna JC and Alegret M. Bempedoic acid for nonalcoholic fatty liver disease: evidence and mechanisms of action. Curr Opin Lipidol 2023; 34: 141-146.","journal-title":"Curr Opin Lipidol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.surg.2019.09.024","article-title":"Electrical stimulation of the vagus nerve improves intestinal blood flow after trauma and hemorrhagic shock","volume":"167","author":"Yagi","year":"2020","unstructured":"Yagi M, Morishita K, Ueno A, Nakamura H, Akabori H, Senda A, Kojima M, Aiboshi J, Costantini T, Coimbra R and Otomo Y. Electrical stimulation of the vagus nerve improves intestinal blood flow after trauma and hemorrhagic shock. Surgery 2020; 167: 638-645.","journal-title":"Surgery"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.3390\/ijms24054977","article-title":"Treatment with the olive secoiridoid oleacein protects against the intestinal alterations associated with EAE","volume":"24","author":"Guti&#xE9","year":"2023","unstructured":"Gutiérrez-Miranda B, Gallardo I, Melliou E, Cabero I, Álvarez Y, Hernández M, Magiatis P, Hernández M and Nieto ML. Treatment with the olive secoiridoid oleacein protects against the intestinal alterations associated with EAE. Int J Mol Sci 2023; 24: 4977.","journal-title":"Int J Mol Sci"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1097\/hep.0000000000000386","article-title":"Therapeutic modulation of the liver immune microenvironment","volume":"78","author":"Tilg","year":"2023","unstructured":"Tilg H, Adolph TE and Tacke F. Therapeutic modulation of the liver immune microenvironment. Hepatology 2023; 78: 1581-1601.","journal-title":"Hepatology"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"103038","DOI":"10.1016\/j.autneu.2022.103038","article-title":"Transcutaneous vagus nerve stimulation-a brief introduction and overview","volume":"243","author":"Hilz","year":"2022","unstructured":"Hilz MJ. Transcutaneous vagus nerve stimulation-a brief introduction and overview. Auton Neurosci 2022; 243: 103038.","journal-title":"Auton Neurosci"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/diseases12090226","article-title":"Mitochondrial dysfunction in systemic lupus erythematosus: insights and therapeutic potential","volume":"12","author":"Poznyak","year":"2024","unstructured":"Poznyak AV, Orekhov NA, Churov AV, Starodubtseva IA, Beloyartsev DF, Kovyanova TI, Sukhorukov VN and Orekhov AN. Mitochondrial dysfunction in systemic lupus erythematosus: insights and therapeutic potential. Diseases 2024; 12: 226.","journal-title":"Diseases"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"1041070","DOI":"10.3389\/fimmu.2022.1041070","article-title":"Pasture intake protects against commercial diet-induced lipopolysaccharide production facilitated by gut microbiota through activating intestinal alkaline phosphatase enzyme in meat geese","volume":"13","author":"Ali","year":"2022","unstructured":"Ali Q, Ma S, Farooq U, Niu J, Li F, Li D, Wang Z, Sun H, Cui Y and Shi Y. Pasture intake protects against commercial diet-induced lipopolysaccharide production facilitated by gut microbiota through activating intestinal alkaline phosphatase enzyme in meat geese. Front Immunol 2022; 13: 1041070.","journal-title":"Front Immunol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"102563","DOI":"10.1016\/j.cpcardiol.2024.102563","article-title":"A review regarding the article ‘targeting inflammatory signaling pathways with SGLT2 inhibitors: insights into cardiovascular health and cardiac cell improvement’","volume":"49","author":"He","year":"2024","unstructured":"He X and Yuan D. A review regarding the article ‘targeting inflammatory signaling pathways with SGLT2 inhibitors: insights into cardiovascular health and cardiac cell improvement’. Curr Probl Cardiol 2024; 49: 102563.","journal-title":"Curr Probl Cardiol"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Andraka JM, Graham E, Szczesny D, Marchalant Y and Sharma N. Impact of krill oil supplementation on neuroinflammation and spatial memory in aged rats. FASEB J 2022; 36 Suppl 1: R3568.","DOI":"10.1096\/fasebj.2022.36.S1.R3568"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/S0140-6736(24)01744-6","article-title":"Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial","volume":"404","author":"Rodgers","year":"2024","unstructured":"Rodgers A, Salam A, Schutte AE, Cushman WC, de Silva HA, Di Tanna GL, Grobbee DE, Narkiewicz K, Ojji DB, Poulter NR, Schlaich MP, Oparil S, Spiering W, Williams B, Wright JT, Lakshman P, Uluwattage W, Hay P, Pereira T, Amarasena N, Ranasinghe G, Gianacas C, Shanthakumar M, Liu X, Wang N, Gnanenthiran SR and Whelton PK; GMRx2 Investigators. Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial. Lancet 2024; 404: 1536-1546.","journal-title":"Lancet"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s10157-021-02062-3","article-title":"Neuroimmune system-mediated renal protection mechanisms","volume":"25","author":"Inoue","year":"2021","unstructured":"Inoue T. Neuroimmune system-mediated renal protection mechanisms. Clin Exp Nephrol 2021; 25: 915-924.","journal-title":"Clin Exp Nephrol"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/joim.12626","article-title":"Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis","volume":"282","author":"Koopman","year":"2017","unstructured":"Koopman FA, van Maanen MA, Vervoordeldonk MJ and Tak PP. Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis. J Intern Med 2017; 282: 64-75.","journal-title":"J Intern Med"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Arribillaga L, Echeverria I, Belsue V, Gomez T, Lozano T, Casares N, Villanueva L, Domingos-Pereira S, Romero PJ, Nardelli-Haefliger D, Hervás-Stubbs S, Sarobe P, Rodriguez MJ, Carrascosa JL, Zürcher T and Lasarte JJ. Bivalent therapeutic vaccine against HPV16\/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16\/18 E7 viral antigens. J Immunother Cancer 2020; 8: e000704.","DOI":"10.1136\/jitc-2020-000704"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/wps.20883","article-title":"The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality","volume":"20","author":"Torous","year":"2021","unstructured":"Torous J, Bucci S, Bell IH, Kessing LV, Faurholt-Jepsen M, Whelan P, Carvalho AF, Keshavan M, Linardon J and Firth J. The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality. World Psychiatry 2021; 20: 318-335.","journal-title":"World Psychiatry"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/5\/ajtr0163166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:33Z","timestamp":1766023053000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/5\/ajtr0163166.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":104,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/zwsr4476","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}